  
  
 Date: 20th November 2025
To
The Deputy Gen. Manager,
Dept.of Corporate Services,
BSE Ltd, P.J. Tower, Dalal Street,
Mumbai – 400 001.
BSE Scrip Code: 524322
Dear Sir/ Madam,
Sub.:     Intimation  of  Board  Meeting  under  Regulation  29  of  SEBI  (Listing  obligations  and   
Disclosure Requirement) Regulations, 2015
Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, 28 th 
November 2025 at 5.00 PM in our Corporate Office No:3, 2nd Floor, Swaminathan Street, West Mambalam, 
Chennai – 600 033 to transact the business as given below: -
1. To recommend the appointment of Ms. Ritu Tiwari as Director of the Company.
2. To recommend the appointment of Ms. Nikita Sinha as Director of the Company.
3. To sign an agreement with MR FRANCHISE to appoint around 200 channel partner throughout  
the Country for expansion.
4. T
o consider and approve appointment of scrutinizer for EGM purpose.
5. To  fix  the  Date,  Time  and  Venue  to  convene  the  Extra-Ordinary  General  meeting  of  the 
Company & the draft Notice calling the EGM.
6. Any othe
r agenda with the permission of the chair.
Kindly take the aforesaid information on record and oblige.
Thanking you,
Yours sincerely,
For Kabra Drugs Limited
Nanjappan Aravind
Managing Director
(DIN: 01895602)

